Daily Digest: Adolescent Risks and Pharmaceutical-Grade Cannabis Progress
This daily digest highlights pharmaceutical-grade CBD clinical trial development and adolescent cannabis exposure risks. Recent studies emphasize measurable harm from adolescent use. Meanwhile, cognitive aging research offers reassurance for older adults.
New Study Reveals How 35 Years of Excessive Drinking Impacts Brain
This study highlights chronic alcohol use endocannabinoid system disruption and its role in cognitive and psychiatric complications. Long-term excessive drinking dysregulates this system, impacting brain functions. Understanding this helps clinicians…
Daily Digest: Last 9 Hours: Cognitive Safety Signals, Adolescent Risk, and the Regulatory Puzzle That Still Defines Cannabis Medicine — March 03, 2026
This digest highlights age-dependent cannabis cognitive effects and their clinical implications. It addresses adolescent neurotoxicity risks and the regulatory puzzle that complicates cannabis medicine. The focus is on bridging clinical evidence with…
Avecho Biotechnology Hits Milestone in Phase 3 Insomnia Trial
Avecho Biotechnology has reached a crucial milestone in its phase 3 insomnia trial cannabidiol study. This large-scale trial aims to provide robust efficacy and safety data for CBD as a treatment option. Clinicians should monitor this trial as it may…
How Cannabis Transforms Animal Medicine
Cannabinoid therapeutics veterinary medicine offers promising parallels to human treatments, especially for pain and seizure control. Veterinary research helps establish dosing and safety profiles relevant to clinical practice. This emerging field…
Can I Get Pulled Over for Smelling Like Weed in WA? How Cannabis DUI Laws Work
Cannabis DUI laws Washington create unique challenges for patients using THC therapeutically. These laws allow officers to pull over drivers based on the smell of weed alone. Understanding cannabis impairment in Washington is crucial for safe driving and…
Daily Digest: Cannabis and Anxiety Risk in the Long Run — March 03, 2026
This digest reviews new cohort data on cannabis and anxiety risk long term. While cannabis may offer short-term relief, sustained use shows complex anxiety outcomes. Dr. Caplan provides clinical context on these findings.
Cannabinoid Hyperemesis Syndrome: What Symptoms to Watch For
Cannabinoid hyperemesis syndrome symptoms include cyclical nausea, vomiting, and abdominal pain in chronic cannabis users. Early recognition of these symptoms is critical to avoid unnecessary interventions. Understanding cannabinoid hyperemesis syndrome…
Current Status of Medical Cannabis Access in the UK
The current status of UK medical cannabis access remains restrictive despite legal rescheduling. Barriers in prescribing and patient access persist due to stringent evidence requirements. Understanding these challenges is essential for clinicians and…
Rising Cases of Cannabis Hyperemesis Syndrome Across the US
Cannabis hyperemesis syndrome cases surge nationwide as chronic cannabis use increases. This syndrome causes cyclic nausea, vomiting, and abdominal pain in users. Early recognition and cannabis cessation are critical for effective management.
